Status and phase
Conditions
Treatments
About
The purpose of this study is to assess the pharmacodynamics, safety and efficacy of omiganan in patients with external genital warts.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Eligible subjects must meet none of the following exclusion criteria at screening:
Primary purpose
Allocation
Interventional model
Masking
24 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal